SCHEMBL19935708

SCHEMBL19935708

O=NC(=O)c1ncc(-c2cccc(Cl)c2)cc1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 9/20 0.60
EGLN3 Q9H6Z9 4/20 0.60
VEGFA P15692 3/20 0.60
FLT1 P17948 3/20 0.60
TET3 O43151 1/20 0.60
BBOX1 O75936 1/20 0.60
ASPH Q12797 1/20 0.60
TET2 Q6N021 1/20 0.60
KDM8 Q8N371 1/20 0.60
OGFOD1 Q8N543 1/20 0.60
TET1 Q8NFU7 1/20 0.60
HIF1AN Q9NWT6 1/20 0.60
ALOX5 P09917 1/20 0.47
GRIN2B Q13224 3/20 0.42
GRIN1 Q05586 1/20 0.42
MAP4K4 O95819 1/20 0.41
FYN P06241 1/20 0.41
ESR2 Q92731 1/20 0.41
KMO O15229 1/20 0.41
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30514566 0.87 EGLN1 (0.68) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL4370919 0.87 EGLN1 (0.68) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL3031409 0.83 EGLN1 (0.63) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL30346108 0.83 EGLN1 (0.63) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL3031405 0.83 EGLN1 (0.63) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL19393710 0.83 EGLN1 (0.63) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL25241500 0.80 EGLN1 (0.69) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL30748269 0.80 EGLN1 (0.69) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL30432292 0.80 EGLN1 (0.69) EGLN1EGLN3VEGFAFLT1TET3
SCHEMBL1921043 0.79 EGLN1 (0.65) EGLN1EGLN3VEGFAFLT1TET3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4026829-A1 PROCESS FOR PREPARING N-[[5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINYL]CARBONYL]-GLYCINE FROM 5-(3-CHLOROPHENYL)-3-HYDROXY-2-PYRIDINE CARBOXYLIC ACID Akebia Therapeutics Inc. (US) 2022-07-13 EP disclosed
EP-3683209-A1 PROCESS FOR PREPARING [(5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ACETIC ACID FROM 5-((3-CHLOROPHENYL)-3-CHLORO-PYRIDIN-2-YL)-NITRILE, AND PROCESS FOR PREPARING 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES Akebia Therapeutics Inc. (US) 2020-07-22 EP disclosed
EP-3290404-A1 5-((HALOPHENYL)-3-HALO-PYRIDIN-2-YL)-NITRILE DERIVATIVES AS INTERMEDIATES IN THE PREPARATION OF [(5-(HALOPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL)-AMINO]ALKANOIC ACID DERIVATIVES Akebia Therapeutics Inc. (US) 2018-03-07 EP disclosed
EP-3000808-B1 5-((HALOPHENYL)-3-HYDROXY-PYRIDIN-2-YL)-CARBOXYLIC ACID DERIVATIVES AS INTERMEDIATES FOR THE PREPARATION OF CARBONYLAMINO ALKANOIC ACIDS, ESTERS AND AMIDES THEREOF AKEBIA THERAPEUTICS INC (US) 2017-09-27 EP disclosed